CATALOGO DEI PRODOTTI DELLA RICERCA

FRACASSI, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.349
EU - Europa 3.556
AS - Asia 2.539
SA - Sud America 395
Continente sconosciuto - Info sul continente non disponibili 123
AF - Africa 85
OC - Oceania 8
Totale 11.055
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.191
RU - Federazione Russa 1.280
SG - Singapore 1.011
GB - Regno Unito 832
CN - Cina 670
IT - Italia 449
BR - Brasile 319
VN - Vietnam 206
SE - Svezia 205
HK - Hong Kong 187
DE - Germania 179
FR - Francia 151
IE - Irlanda 142
FI - Finlandia 141
BD - Bangladesh 112
CA - Canada 73
KR - Corea 71
TR - Turchia 64
IN - India 51
JP - Giappone 51
UA - Ucraina 40
AR - Argentina 27
IQ - Iraq 24
NL - Olanda 22
MX - Messico 21
AT - Austria 18
ES - Italia 18
ZA - Sudafrica 18
BE - Belgio 17
EC - Ecuador 14
LT - Lituania 13
NG - Nigeria 13
NP - Nepal 13
ID - Indonesia 12
PL - Polonia 12
PK - Pakistan 11
GT - Guatemala 10
CO - Colombia 9
BJ - Benin 8
EG - Egitto 8
PE - Perù 8
SA - Arabia Saudita 8
SV - El Salvador 8
CR - Costa Rica 7
CZ - Repubblica Ceca 7
IL - Israele 7
IR - Iran 7
JM - Giamaica 7
MA - Marocco 7
PR - Porto Rico 7
AU - Australia 6
TG - Togo 6
TT - Trinidad e Tobago 6
VE - Venezuela 6
CH - Svizzera 5
CW - ???statistics.table.value.countryCode.CW??? 5
GR - Grecia 5
HN - Honduras 5
PY - Paraguay 5
SC - Seychelles 5
CL - Cile 4
KE - Kenya 4
LB - Libano 4
NI - Nicaragua 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BO - Bolivia 3
RO - Romania 3
SI - Slovenia 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
GP - Guadalupe 2
JO - Giordania 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
PH - Filippine 2
PT - Portogallo 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
CD - Congo 1
CM - Camerun 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
HR - Croazia 1
Totale 10.922
Salva come PNG Salva come JPEG
Città #
Southend 703
Ashburn 570
Singapore 565
Moscow 449
San Jose 432
Dallas 343
Chandler 329
Jacksonville 263
Hong Kong 183
Ann Arbor 174
Dublin 142
Council Bluffs 134
Woodbridge 132
Beijing 126
Verona 122
Houston 104
The Dalles 102
New York 96
Los Angeles 92
Ho Chi Minh City 72
Milan 63
Santa Clara 54
Princeton 53
Lawrence 51
Wilmington 51
Hanoi 49
Tokyo 47
Jinan 46
Munich 39
São Paulo 37
Nanjing 36
Shenyang 36
Helsinki 33
Redmond 30
Buffalo 28
Redondo Beach 24
Turku 23
London 21
Columbus 20
Zhengzhou 20
Atlanta 18
Ningbo 18
Orem 18
Phoenix 18
Tianjin 18
Haikou 17
Hebei 17
Boardman 16
Brooklyn 16
Brussels 16
Montreal 16
Amsterdam 15
Changsha 15
Boston 14
Chicago 14
Denver 14
Falkenstein 14
Fuzhou 14
North Bergen 14
Rome 14
Sindelfingen 14
Taizhou 14
Seattle 13
Washington 13
Abuja 12
Charlotte 12
Redwood City 12
San Francisco 12
Taiyuan 12
Baghdad 11
Detroit 11
Jiaxing 11
Johannesburg 11
Kathmandu 11
Nanchang 11
Rio de Janeiro 11
Chennai 10
Da Nang 10
Frankfurt am Main 10
Guangzhou 10
Lappeenranta 10
Toronto 10
Düsseldorf 9
Guatemala City 9
Hangzhou 9
Lancaster 9
Orani 9
Poplar 9
Ankara 8
Belo Horizonte 8
Cagliari 8
Cotonou 8
Jakarta 8
Mexico City 8
Norwalk 8
Stockholm 8
Turin 8
Vienna 8
Warsaw 8
Manchester 7
Totale 6.610
Salva come PNG Salva come JPEG
Nome #
Artrite Reumatoide e Metabolismo Minerale 295
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis 285
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 269
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 264
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 238
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 234
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 228
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 220
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 218
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 198
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 196
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 190
Osteopetrosi 188
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 185
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 185
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 183
Vitamina D e artrite reumatoide 182
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 181
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis 181
Sclerostin and DKK1 in primary hyperparathyroidism. 180
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 179
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 177
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 176
Invecchiamento dell'apparato scheletrico 175
Prevalence of osteoporosis in patients affected by mastocytosis 175
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis 174
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 169
Artropatie degenerative 166
Development and First Validation of a Disease Activity Score for Gout 165
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 160
Focal bone involvement in inflammatory arthritis: the role of IL17 159
Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol 156
Changes in bone turnover markers and bone modulators during abatacept treatment 155
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 152
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 151
Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases 149
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 148
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 148
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 145
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 145
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 143
Comparison and potential determinants of health-related quality of life among rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: A cross-sectional study 143
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 142
Depression as a possible determinant of fatigue in patients with axial spondyloarthritis 141
Osteoporosi 137
Long-term effects of neridronate and its discontinuation in patients with primary hyperparathyroidism 136
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 136
Neridronic acid for the treatment of bone metabolic diseases 132
Previous use of amino-bisphosphonates and circulating gamma/delta T cells 131
Efficacy and safety of digital nerve block for pain management during sharp debridement of digital ulcers in systemic sclerosis: A prospective observational study 130
Osteoporosis Treatment: When to Discontinue and When to Re-start 129
Vitamin D and rheumatic diseases. 129
Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight 124
Vitamin D and fractures: a systematic review 122
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 122
The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1 120
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture. 112
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 111
Gender differences in psychological features and determinates of quality of life in axial spondyloarthritis and psoriatic arthritis: a cross-sectional study 109
Treatment with secukinumab in multi-comorbid patients with psoriatic arthritis 108
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis 107
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement 105
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 104
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 104
Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis,Razionale e risultati del trattamento settimanale con calcifediolo nell'osteoporosi postmenopausale e senile 103
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 103
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 102
The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta. 98
Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report 85
Coping strategies, depression, anxiety and fatigue in rheumatic diseases: A moderated mediation analysis 29
Parvovirus B19 infection with rheumatologic manifestations: results from a multicentre Italian study 17
Prevalence and determinants of state and trait anxiety in inflammatory rheumatic diseases 17
Totale 11.055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.062
article - articoli 34.733
book - libri 0
conference - conferenze 717
curatela - curatele 0
other - altro 529
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.083
Totale 76.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022250 0 0 0 0 25 18 7 22 42 7 35 94
2022/2023979 67 106 81 176 53 239 10 68 118 17 33 11
2023/2024532 22 30 43 52 69 93 23 65 7 14 75 39
2024/20251.464 67 77 73 217 78 60 88 65 214 132 129 264
2025/20264.510 298 249 309 809 1.080 311 433 233 275 213 144 156
2026/2027999 77 122 183 491 126 0 0 0 0 0 0 0
Totale 11.055